Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14 ARF –Mdm2–P53-dependent cellular senescence

Haibin Wang; Guoxing Xu; Zhengjie Huang; Weizheng Li; Huali Cai; Yunda Zhang; Disheng Xiong; Gang Liu; Shengjie Wang; Zengfu Xue; Qi Luo

doi:10.18632/oncotarget.26283

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14^ARF–Mdm2–P53-dependent cellular senescence

PDF | How to cite

Oncotarget. 2018; 9:35512-35512. https://doi.org/10.18632/oncotarget.26283

Metrics: PDF 1708 views | ?

Haibin Wang^1,*, Guoxing Xu^2,*, Zhengjie Huang^1,3,*, Weizheng Li⁴, Huali Cai¹, Yunda Zhang¹, Disheng Xiong¹, Gang Liu¹, Shengjie Wang¹, Zengfu Xue⁴ and Qi Luo¹

¹ Department of Gastrointestinal Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China
² Department of Endoscopy Center, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China
³ Department of Gastrointestinal Surgery, First Clinical Medical College of Fujian Medical University, Fuzhou 350004, China
⁴ Department of Cancer Prevention, Diagnosis and Treatment, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China
^* These authors have contributed equally to this work

Published: October 26, 2018

This article has been corrected: The correct Title information is given below:

NLRP6 targeting suppresses gastric tumorigenesis via P14^ARF–Mdm2–P53-dependent cellular senescence

Original article: Oncotarget. 2017; 8:111597-111607. DOI: https://doi.org/10.18632/oncotarget.22876.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26283

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14^ARF–Mdm2–P53-dependent cellular senescence

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14ARF–Mdm2–P53-dependent cellular senescence

Correction: NLRP6 targeting suppresses gastric tumorigenesis via P14^ARF–Mdm2–P53-dependent cellular senescence